Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage

Neurology

Volumn 72, Issue 16, 2009, Pages 1376-1377

  Broderick, Joseph P ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATININE; DISUFENTON SODIUM; GLUCOSE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN; BLOOD CLOTTING FACTOR 7A; COAGULATING AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

BODY MASS; BRAIN HEMORRHAGE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DETERIORATION; EDITORIAL; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; METHODOLOGY; NOTE; PROSPECTIVE STUDY; STATISTICS; TIME;

ACUTE DISEASE; CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; COAGULANTS; EMERGENCY MEDICAL SERVICES; FACTOR VIIA; HUMANS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 67449119358     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000343513.94534.d2     Document Type: Editorial

References (11)

1. Davis SM, Broderick J, Hennerici M, et al., for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-1181.
2. Broderick J, Connolly S, Feldmann E, et al., for the American Heart Association, American Stroke Association Stroke Council, High Blood Pressure Research Council, and Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023.
3. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
4. Broderick JP, Diringer MN, Hill MD, et al., for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007;38: 1072-1075.
5. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology 2008; 71:1084-1089.
6. Cucchiara BL, Messe SR, Sansing LH, Kasner SE, Lyden PD, for the CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 2008;39:2993-2996.
7. Goldstein JN, Rosand J, Schwamm LH. Warfarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 2008;9:277-283.
8. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE, for the CHANT Investigators. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 2009;72:1397-1402.
9. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
10. Mayer SA, Brun NC, Begtrup K, et al., for the FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-2137.
11. Anderson CS, Huang Y, Wang JG, et al., for the INTERACT Investigators. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008;7:391-399.